Anna Krasnianski

1.9k total citations
34 papers, 1.1k citations indexed

About

Anna Krasnianski is a scholar working on Molecular Biology, Neurology and Psychiatry and Mental health. According to data from OpenAlex, Anna Krasnianski has authored 34 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 14 papers in Neurology and 6 papers in Psychiatry and Mental health. Recurrent topics in Anna Krasnianski's work include Prion Diseases and Protein Misfolding (29 papers), Neurological diseases and metabolism (14 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (5 papers). Anna Krasnianski is often cited by papers focused on Prion Diseases and Protein Misfolding (29 papers), Neurological diseases and metabolism (14 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (5 papers). Anna Krasnianski collaborates with scholars based in Germany, United Kingdom and Spain. Anna Krasnianski's co-authors include Inga Zerr, Uta Heinemann, Bettina Meißner, Daniela Varges, Walter Schulz‐Schaeffer, Kai Kallenberg, Hans A. Kretzschmar, H. A. Kretzschmar, E. M. Grasbon-Frodl and Bernhard J. Steinhoff and has published in prestigious journals such as Brain, Neurology and Annals of Neurology.

In The Last Decade

Anna Krasnianski

33 papers receiving 1.1k citations

Peers

Anna Krasnianski
Anna Krasnianski
Citations per year, relative to Anna Krasnianski Anna Krasnianski (= 1×) peers Gianfranco Puoti

Countries citing papers authored by Anna Krasnianski

Since Specialization
Citations

This map shows the geographic impact of Anna Krasnianski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Krasnianski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Krasnianski more than expected).

Fields of papers citing papers by Anna Krasnianski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Krasnianski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Krasnianski. The network helps show where Anna Krasnianski may publish in the future.

Co-authorship network of co-authors of Anna Krasnianski

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Krasnianski. A scholar is included among the top collaborators of Anna Krasnianski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Krasnianski. Anna Krasnianski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Varges, Daniela, Uta Heinemann, Claudia Ponto, et al.. (2016). Doxycycline in early CJD: a double-blinded randomised phase II and observational study. Journal of Neurology Neurosurgery & Psychiatry. 88(2). 119–125. 57 indexed citations
2.
Krasnianski, Anna, et al.. (2015). Psychiatric Symptoms in Patients With Sporadic Creutzfeldt-Jakob Disease in Germany. The Journal of Clinical Psychiatry. 76(9). 1209–1215. 17 indexed citations
3.
Krasnianski, Anna, Uta Heinemann, Claudia Ponto, et al.. (2015). Clinical findings and diagnosis in genetic prion diseases in Germany. European Journal of Epidemiology. 31(2). 187–196. 23 indexed citations
4.
Krasnianski, Anna, et al.. (2014). First symptom and initial diagnosis in sporadic CJD patients in Germany. Journal of Neurology. 261(9). 1811–1817. 25 indexed citations
5.
Krasnianski, Anna, Pascual Sánchez‐Juan, Michael Bartl, et al.. (2013). A proposal of new diagnostic pathway for fatal familial insomnia. Journal of Neurology Neurosurgery & Psychiatry. 85(6). 654–659. 34 indexed citations
6.
Meißner, Bettina, Kai Kallenberg, Pascual Sánchez‐Juan, et al.. (2009). MRI and clinical syndrome in dura materrelated Creutzfeldt-Jakob disease. Journal of Neurology. 256(3). 355–363. 17 indexed citations
7.
Krasnianski, Anna, Kai Kallenberg, Donald A. Collie, et al.. (2008). MRI in the classical MM1 and the atypical MV2 subtypes of sporadic CJD: an inter‐observer agreement study. European Journal of Neurology. 15(8). 762–771. 14 indexed citations
8.
Heinemann, Uta, et al.. (2008). Quantitative Analysis of Transthyretin, Tau and Amyloid-β in Patients with Dementia. Journal of Alzheimer s Disease. 14(1). 17–25. 85 indexed citations
9.
Krasnianski, Anna, Uta Heinemann, Bettina Meißner, et al.. (2008). Fatal familial insomnia: Clinical features and early identification. Annals of Neurology. 63(5). 658–661. 46 indexed citations
10.
Meißner, Bettina, Kai Kallenberg, Pascual Sánchez‐Juan, et al.. (2008). Isolated Cortical Signal Increase on MR Imaging as a Frequent Lesion Pattern in Sporadic Creutzfeldt-Jakob Disease. American Journal of Neuroradiology. 29(8). 1519–1524. 47 indexed citations
11.
Heinemann, Uta, Anna Krasnianski, Bettina Meißner, et al.. (2008). Novel PRNP mutation in a patient with a slow progressive dementia syndrome. PubMed. 14(5). CS41–43. 13 indexed citations
12.
Krasnianski, Anna, Nicolas von Ahsen, Uta Heinemann, et al.. (2007). ApoE Distribution and Family History in Genetic Prion Diseases in Germany. Journal of Molecular Neuroscience. 34(1). 45–50. 7 indexed citations
13.
Heinemann, Uta, et al.. (2007). Molecular subtype-specific clinical diagnosis of prion diseases. Veterinary Microbiology. 123(4). 328–335. 5 indexed citations
14.
Heinemann, Uta, Anna Krasnianski, Bettina Meißner, et al.. (2007). Creutzfeldt-Jakob disease in Germany: a prospective 12-year surveillance. Brain. 130(5). 1350–1359. 135 indexed citations
15.
Krasnianski, Anna, Bettina Meißner, Walter Schulz‐Schaeffer, et al.. (2006). Clinical Features and Diagnosis of the MM2 Cortical Subtype of Sporadic Creutzfeldt-Jakob Disease. Archives of Neurology. 63(6). 876–876. 61 indexed citations
16.
Schulz‐Schaeffer, Walter, Monika Bodemer, Barbara Ciesielczyk, et al.. (2006). Brain-derived proteins in the CSF, do they correlate with brain pathology in CJD?. BMC Neurology. 6(1). 35–35. 20 indexed citations
17.
Krasnianski, Anna. (2006). Clinical findings and diagnostic tests in the MV2 subtype of sporadic CJD. Brain. 129(9). 2288–2296. 63 indexed citations
18.
Schulz‐Schaeffer, Walter, Bettina Meißner, Kai Kallenberg, et al.. (2005). Clinical course in young patients with sporadic Creutzfeldt–Jakob disease. Annals of Neurology. 58(4). 533–543. 39 indexed citations
19.
Krasnianski, Anna, Marcus Deschauer, Stephan Neudecker, et al.. (2005). Mitochondrial changes in skeletal muscle in amyotrophic lateral sclerosis and other neurogenic atrophies. Brain. 128(8). 1870–1876. 68 indexed citations
20.
Deschauer, Marcus, Anna Krasnianski, Stephan Zierz, & Robert W. Taylor. (2004). False-Positive Diagnosis of a Single, Large-Scale Mitochondrial DNA Deletion by Southern Blot Analysis: The Role of Neutral Polymorphisms. Genetic Testing. 8(4). 395–399. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026